News
PET scan at diagnosis may help to predict aneurysm risk in patients with giant cell arteritis
Patients with aortic inflammation detected by PET were at greater risk for developing aortic aneurysms, particularly thoracic aortic aneurysms.
News
FDA approves first tocilizumab biosimilar
Tocilizumab-bavi (Tofidence) will offer a lower-cost option for patients with autoimmune conditions, the drug manufacturer, Biogen, stated.
News
Are cellular therapies the future of autoimmune disease?
Promising results from small case studies and early clinical trials hint at the potential of CAR T-cell therapy to treat – and possibly cure –...
News
Colchicine still needed to prevent gout flares in allopurinol ‘start-low, go-slow’ strategy
Patients taking colchicine had fewer gout flares than did those taking placebo for the first 6 months, but the number evened out between the two...
News
Precision blood test for rheumatoid arthritis receives Medicare coverage
The test helps to determine if patients with rheumatoid arthritis are unlikely to respond to anti-TNF therapies.
News
ACR: Rheumatologists help reduce ED, hospitalization costs
Rheumatologists can save health systems more than $2,700 per patient per year, and each can generate $3.5 million in annual billings, according to...
News
Industry funding falls for rheumatology research
Research-associated payments dipped by 24% from 2014 to 2022, new data suggest.
News
FDA approves canakinumab for gout flares
Canakinumab is the first biologic in the U.S. approved for treating gout flares.
News
ACR releases guideline for managing ILD in patients with rheumatic disease
“Guidance was needed for which tests to use for screening and monitoring this particular disease,” said lead author Sindhu R. Johnson, MD, PhD....
News
FDA warns AstraZeneca over ‘misleading claims’ about COPD drug
The FDA issued the warning letter on Aug. 4 and published it on Aug. 15.
News
Autoantibody against enteric nervous system protein linked to GI dysfunction in systemic sclerosis
If validated as a biomarker, antigephyrin autoantibodies could help identify patients at higher risk for GI symptoms like constipation.
News
Low-dose steroids may not increase cardiovascular risk in rheumatoid arthritis
A daily prednisolone dose of less than 5 mg was not associated with increased cardiovascular risk, whereas a dose of 5 mg or more doubled the risk...
News
Disclosure inaccuracies common in top rheumatology journals
Nearly 90% of authors with potential conflicts of interest either underreported or did not report disclosures.
News
Autoantibodies could help predict cancer risk in scleroderma
The autoantibodies anti-POLR3 and monospecific anti-Ro52 were associated with increased cancer risk, while anti-centromere and anti-U1RNP were...
News
Tools may predict inflammatory arthritis in at-risk patients
The two tool scores could help determine who can be managed in primary care and who may qualify for intervention studies.